Announcements Trials
Browse Landscape

Phase

Phase 2 63Phase 3 25Phase 1 8Phase 1/2 5Phase 2/3 2Phase 4 1

Status

Completed 5Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 4Gastrointestinal 1Dermatologic 1

Conditions

Carcinoma, Renal Cell 4Kidney Neoplasms 2Rectal Neoplasms 1Neoplasms 1Melanoma 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Cisplatin 111Carboplatin 111pembrolizumab 109Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Interferon-alpha × Clear all
NCT00891475 2014-02-13

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

Kidney Cancer Research Bureau

Phase 1/2 Completed
114 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00003585 2013-12-10

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

University of New Mexico

Phase 1/2 Completed
35 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00030342 2013-06-26

Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

National Cancer Institute (NCI)

Phase 1/2 Completed
60 enrolled
GastrointestinalGenitourinary

Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00005615 2012-09-25

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

H. Lee Moffitt Cancer Center and Research Institute

Phase 1/2 Completed
24 enrolled
Dermatologic

Melanoma

NCT00277017 2011-09-27

Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma

New Mexico Cancer Research Alliance

Phase 1/2 Completed
15 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡